Literature DB >> 25725595

The relevance of EPA guidance papers in the framework of the European Psychiatric Association.

R Heun1, W Gaebel2.   

Abstract

Mesh:

Year:  2015        PMID: 25725595     DOI: 10.1016/j.eurpsy.2015.02.001

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


× No keyword cloud information.
  5 in total

1.  The EPA guidance document series.

Authors:  Wolfgang Gaebel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-03       Impact factor: 5.270

2.  EPA guidance on the quality of mental health services: A systematic meta-review and update of recommendations focusing on care coordination.

Authors:  W Gaebel; A Kerst; B Janssen; T Becker; M Musalek; W Rössler; M Ruggeri; G Thornicroft; J Zielasek; J Stricker
Journal:  Eur Psychiatry       Date:  2020-07-24       Impact factor: 5.361

3.  Compulsory admissions of patients with mental disorders: State of the art on ethical and legislative aspects in 40 European countries.

Authors:  D Wasserman; G Apter; C Baeken; S Bailey; J Balazs; C Bec; P Bienkowski; J Bobes; M F Bravo Ortiz; H Brunn; Ö Bôke; N Camilleri; B Carpiniello; J Chihai; E Chkonia; P Courtet; D Cozman; M David; G Dom; A Esanu; P Falkai; W Flannery; K Gasparyan; G Gerlinger; P Gorwood; O Gudmundsson; C Hanon; A Heinz; M J Heitor Dos Santos; A Hedlund; F Ismayilov; N Ismayilov; E T Isometsä; L Izakova; A Kleinberg; T Kurimay; S Klæbo Reitan; D Lecic-Tosevski; A Lehmets; N Lindberg; K A Lundblad; G Lynch; C Maddock; U F Malt; L Martin; I Martynikhin; N O Maruta; F Matthys; R Mazaliauskiene; G Mihajlovic; A Mihaljevic Peles; V Miklavic; P Mohr; M Munarriz Ferrandis; M Musalek; N Neznanov; G Ostorharics-Horvath; I Pajević; A Popova; P Pregelj; E Prinsen; C Rados; A Roig; M Rojnic Kuzman; J Samochowiec; N Sartorius; Y Savenko; O Skugarevsky; E Slodecki; A Soghoyan; D S Stone; R Taylor-East; E Terauds; C Tsopelas; C Tudose; S Tyano; P Vallon; R J Van der Gaag; P Varandas; L Vavrusova; P Voloshyn; J Wancata; J Wise; Z Zemishlany; F Öncü; S Vahip
Journal:  Eur Psychiatry       Date:  2020-08-24       Impact factor: 5.361

4.  EPA guidance on treatment of negative symptoms in schizophrenia.

Authors:  S Galderisi; S Kaiser; I Bitter; M Nordentoft; A Mucci; M Sabé; G M Giordano; M Ø Nielsen; L B Glenthøj; P Pezzella; P Falkai; S Dollfus; W Gaebel
Journal:  Eur Psychiatry       Date:  2021-03-17       Impact factor: 5.361

5.  EPA guidance on assessment of negative symptoms in schizophrenia.

Authors:  S Galderisi; A Mucci; S Dollfus; M Nordentoft; P Falkai; S Kaiser; G M Giordano; A Vandevelde; M Ø Nielsen; L B Glenthøj; M Sabé; P Pezzella; I Bitter; W Gaebel
Journal:  Eur Psychiatry       Date:  2021-02-18       Impact factor: 5.361

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.